Stock GILD GILEAD SCIENCES, INC.
Add to a list

Connections Gilead Sciences, Inc.

Equities

GILD

US3755581036

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 21:00:00 12/12/2025 GMT 		5-day change 1st Jan Change
120.40 USD -2.28% Intraday chart for Gilead Sciences, Inc. -0.68% +30.35%
12-12 Arcus Biosciences, Inc. Provides Update on Phase 3 Star-221 Study and Concentrates Its R&D Investment on Cas Datifan and Emerging Inflammation and Immunology Portfolio CI
12-12 Arcus, Gilead to Discontinue Phase 3 Trial of Potential Cancer Treatment -- Update DJ

49

Listed companies

34

Private companies

288

Insiders

Relation chart of related listed companies: Gilead Sciences, Inc.

Active Relations

Past Relations

Related listed companies: Gilead Sciences, Inc.

LAM RESEARCH CORPORATION
Jyoti Mehra
STARBUCKS CORPORATION
Aranthan Jones
TRANSCAT, INC.
Robert Mecca
WHIRLPOOL CORPORATION
Harish M. Manwani
NEKTAR THERAPEUTICS
Diana Brainard
NEUROCRINE BIOSCIENCES, INC.
Johanna Mercier
DAVITA INC.
Javier Rodriguez
AGILENT TECHNOLOGIES, INC.
Joydeep Ganguly
EXELIXIS, INC.
Susan T. Hubbard
Christopher Senner
CORCEPT THERAPEUTICS INCORPORATED
Gregg Alton
Amy E. Flood
Monica Tellado
William Guyer
CYTOKINETICS, INCORPORATED
Jeffrey Hessekiel
Sung Lee
ACUMEN PHARMACEUTICALS, INC.
Derrell Porter
ATRICURE, INC.
Deborah Telman
GALAPAGOS NV
Linda Higgins
NURIX THERAPEUTICS, INC.
Roy Baynes
Roger Dansey
FIGMA, INC.
Kelly Kramer
GUARDANT HEALTH, INC.
Gulshan H. Shaver
Christopher Freeman
CARIBOU BIOSCIENCES, INC.
David Johnson
ODYSSEY HEALTH, INC.
Erik Emerson
KURA ONCOLOGY, INC.
Helen Collins
PHARMING GROUP N.V.
Kenneth Lynard
ZENTIVA,
Kenneth Lynard
INOVIO PHARMACEUTICALS, INC.
Roger Dansey
ZENTIVA S.A.
Kenneth Lynard
BLACKSTONE INC.
Harish M. Manwani
BICYCLE THERAPEUTICS PLC
Alessandro Riva
Roger Dansey
THE CARLYLE GROUP INC.
Anthony Welters
JAZZ PHARMACEUTICALS PLC
Ted Love
Laura Hamill
ASSEMBLY BIOSCIENCES, INC.
Jason Okazaki
Jennifer A. Troia
John McHutchison
Tomas Cihlar
Nicole White
Anuj Gaggar
Robert Cook
SNOWFLAKE INC.
Kelly Kramer
REVOLUTION MEDICINES, INC.
Sandra Horning
C4 THERAPEUTICS, INC.
Utpal Koppikar
XILIO THERAPEUTICS, INC.
Yuan Xu
ARCUS BIOSCIENCES, INC.
Linda Higgins
Dietmar Berger
Johanna Mercier
ELANCO ANIMAL HEALTH INCORPORATED
Stacey Ma
OLEMA PHARMACEUTICALS, INC.
Sandra Horning
MODERNA, INC.
Sandra Horning
PASSAGE BIO, INC.
Derrell Porter
COINBASE GLOBAL, INC.
Kelly Kramer
STRUCTURE THERAPEUTICS INC.
Ted Love
ROYALTY PHARMA PLC
Ted Love
ALX ONCOLOGY HOLDINGS INC.
Chris Takimoto
Harish Shantharam
VERA THERAPEUTICS, INC.
James Meyers
Andrew Cheng
David Johnson
Marshall Fordyce
BRII BIOSCIENCES LIMITED
Gregg Alton
Tai Yin Yang
Lian Hong Xu
DAY ONE BIOPHARMACEUTICALS, INC.
Jeremy Bender
William Grossman
SURROZEN, INC.
Shao Lee Lin
IO BIOTECH, INC.
Helen Collins
SEPTERNA, INC.
Elizabeth Bhatt
Samira Shaikhly
ENLIVEN THERAPEUTICS, INC.
Helen Collins

Active Relations

Past Relations

Relationship chart for related private companies: Gilead Sciences, Inc.

Active Relations

Past Relations

Related private companies: Gilead Sciences, Inc.

CymaBay Therapeutics, Inc.

Biotechnology

Andrew Dickinson
Deborah Telman
Biotechnology Innovation Organization

Miscellaneous Commercial Services

John Milligan
James Meyers
Ted Love
James Sapirstein
Grace Colón
Atreca, Inc.

Philippe C. Bishop
Stacey Ma
MPM BioImpact LLC

Investment Managers

Pankaj Bhargava
Diana Brainard
American Chemical Society

Miscellaneous Commercial Services

Tai Yin Yang
John Begley
California Institute of Technology

Other Consumer Services

Jacqueline Barton
Gayle Edlund Wilson
The University of California, San Francisco

Other Consumer Services

Rebecca Coleman
Carol Brosgart
Jeffrey Bluestone
Council on Foreign Relations, Inc.

Investment Trusts/Mutual Funds

Carla A. Hills
John Madigan
American Society of Clinical Oncology, Inc.

Medical/Nursing Services

Julie Cherrington
Roy Baynes
National Academy of Sciences

Miscellaneous Commercial Services

Jacqueline Barton
Jeffrey Bluestone
American Academy of Arts & Sciences

Miscellaneous Commercial Services

Anthony Welters
Jacqueline Barton
Jeffrey Bluestone
National Academy of Engineering

Miscellaneous Commercial Services

Howard Rosen
Tai Yin Yang
National Academy of Medicine (United States)

Miscellaneous Commercial Services

Jacqueline Barton
Jeffrey Bluestone
The State Bar of California

Miscellaneous Commercial Services

Mark Perry
Jason Okazaki
Brett Pletcher
Morehouse School of Medicine

Other Consumer Services

Anthony Welters
Kevin Lofton
American Society of Hematology

Miscellaneous Commercial Services

Julie Cherrington
Roy Baynes
23andMe, Inc.

Medical Specialties

Elvia Cowan
Monica Viziano
Drug Information Association

Miscellaneous Commercial Services

Tai Yin Yang
Martine Kraus
Accelerator Services Corp

Investment Managers

Melissa Yeager
John Latham
Forty Seven, Inc.

Pharmaceuticals: Major

Andrew Dickinson
Brett Pletcher
Mark Chao
Gilead Foundation

Gregg Alton
Joydeep Ganguly
Gilead Sciences Europe Ltd.

Pharmaceuticals: Major

Robin Washington
Brett Pletcher
Gilead Sciences International Ltd.

Other Consumer Services

Robin Washington
Brett Pletcher
Gilead Sciences GmbH

Pharmaceuticals: Major

Robin Washington
Brett Pletcher
Syncona Partners LLP

Lisa Bright
Kate Butler
Stanford University School of Medicine

Paul A. Berg
George Tidmarsh
Sandra Horning
Baruch S. Blumberg Institute

Carol Brosgart
Michael Sofia
Amygdala Neurosciences, Inc.

Louis Lange
William Lee
Tizona Therapeutics, Inc.

Linda Higgins
Pankaj Bhargava
William Grossman
TeneoBio, Inc.

Jeff Bird
Michael Bigham
Gilead Sciences Ltd.

Andrew Dickinson
Brett Pletcher
Kite Pharma UK Ltd.

Robin Washington
Jason Okazaki
Brett Pletcher
Eikon Therapeutics, Inc.

Robin Washington
Roy Baynes
OrsoBio Inc

Muzammil Mansuri
Mani Subramanian

Active Relations

Past Relations

Connection statistics

Active

Inactive

Listed companies

Private companies

Activities of related companies

Pharmaceuticals: Major11
Miscellaneous Commercial Services9
Other Consumer Services4
Biotechnology4
Investment Managers3
Medical Specialties3
Medical/Nursing Services2
Pharmaceuticals: Generic1
Investment Trusts/Mutual Funds1

Countries of related companies

United States69
United Kingdom6
Germany1
Denmark1
China1
Ireland1
Romania1
Slovakia1
Netherlands1
Belgium1

Company Profile

Logo Gilead Sciences, Inc.
Gilead Sciences, Inc. specializes in the development, manufacturing and marketing of therapeutic products. Net sales break down by source of income as follows: - sale of drugs (99.5%): for the treatment of HIV (68.5% of net sales), oncology diseases (11.5%), hepatitis B virus (10.6%), Ebola virus (6.3%) and other (3.1%; primarily cytomegalovirus retinitis, and advanced Kaposi sarcoma resulting from HIV); - other (0.5%): especially royalties and revenue from research and development services and from subcontracted production of therapeutic products. Net sales are distributed geographically as follows: the United States (71.6%), Europe (16.1%) and other (12.3%).
Employees
17,600
Sector
Pharmaceuticals
Calendar
12-14 - Ex-dividend day
More about the company
  1. Stock Market
  2. Equities
  3. GILD Stock
  4. Company Gilead Sciences, Inc.
  5. Connections

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States
United-States
Canada
Canada

MIDDLE EAST

Saudi Arabia
Saudi Arabia
United Arab Emirates
United Arab Emirates

EUROPE

France
France
Deutschland
Deutschland
Suisse
Suisse
Schweiz
Schweiz
Italia
Italia
Österreich
Österreich
België
België
Nederland
Nederland
España
España
Sverige
Sverige
United Kingdom
United Kingdom

APAC

Australia
Australia
India
India
Hong Kong
Hong Kong
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition